Estudios originales

Access to knee arthroplasty among National Health Fund beneficiaries in Chile between 2004 and 2021

Back to article
Percentage of estimated out-of-pocket spending for FONASA patients in two estimated scenarios.
YearGb 1.0Gb 1.2Zero co-payment 1.0Zero co-payment 1.2
200413.70%16.00%-15.70%-13.50%
200515.90%18.50%-17.90%-15.40%
200617.20%19.90%-18.50%-15.90%
200719.20%22.50%-12.60%-10.70%
200813.40%15.60%-19.90%-17.20%
200917.10%20.10%-13.70%-11.60%
201020.40%23.90%-13.40%-11.40%
201120.40%24.00%-12.40%-10.50%
201218.60%21.70%-17.20%-14.80%
201322.90%26.90%-13.90%-11.90%
201430.40%36.10%-7.60%-6.40%
201527.20%32.10%-8.90%-7.50%
201627.20%32.10%-10.00%-8.50%
201726.30%31.00%-10.80%-9.20%
201832.20%38.20%-7.70%-6.50%
201925.60%30.20%-11.00%-9.30%
202035.00%41.40%-7.80%-6.60%
202156.00%66.90%-3.10%-2.60%
Historic24.40%27.20%-11.20%-10.10%

Gb 1.0, FONASA patient pays 100% of the diagnosis-related group cost.Gb 1.2, the patient pays 120% of the diagnosis-related group cost.FONASA, National Health Fund. GB, out-of-pocket expense.

Notes: In addition, the impact on the estimated out-of-pocket expenditure in both scenarios when applying the new Zero Copayment Law is shown.

Source: Prepared by the authors based on the study’s results.